Department of Medicine, Sorlandet Hospital Arendal, Norway; ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Int J Cardiol. 2021 Nov 1;342:56-62. doi: 10.1016/j.ijcard.2021.07.044. Epub 2021 Jul 26.
Recent evidence suggests that an implantable cardioverter defibrillator (ICD) in non-ischemic cardiomyopathy (NICM) may not offer mortality benefit. We aimed to investigate if etiology of heart failure and strain echocardiography can improve risk stratification of life threatening ventricular arrhythmia (VA) in heart failure patients.
This prospective multi-center follow-up study consecutively included NICM and ischemic cardiomyopathy (ICM) patients with left ventricular ejection fraction (LVEF) <40%. We assessed LVEF, global longitudinal strain (GLS) and mechanical dispersion (MD) by echocardiography. Ventricular arrhythmia was defined as sustained ventricular tachycardia, sudden cardiac death or appropriate shock from an ICD.
We included 290 patients (67 ± 13 years old, 74% males, 207(71%) ICM). During 22 ± 12 months follow up, VA occurred in 32(11%) patients. MD and GLS were both markers of VA in patients with ICM and NICM, whereas LVEF was not (p = 0.14). MD independently predicted VA (HR: 1.19; 95% CI 1.08-1.32, p = 0.001), with excellent arrhythmia free survival in patients with MD <70 ms (Log rank p < 0.001). Patients with NICM and MD <70 ms had the lowest VA incidence with an event rate of 3%/year, while patients with ICM and MD >70 ms had highest VA incidence with an event rate of 16%/year.
Patients with NICM and normal MD had low arrhythmic event rate, comparable to the general population. Patients with ICM and MD >70 ms had the highest risk of VA. Combining heart failure etiology and strain echocardiography may classify heart failure patients in low, intermediate and high risk of VA and thereby aid ICD decision strategies.
最近的证据表明,植入式心脏复律除颤器(ICD)在非缺血性心肌病(NICM)中可能无法提供生存获益。我们旨在研究心力衰竭的病因和应变超声心动图是否可以改善心力衰竭患者威胁生命的室性心律失常(VA)的风险分层。
这项前瞻性多中心随访研究连续纳入左心室射血分数(LVEF)<40%的 NICM 和缺血性心肌病(ICM)患者。我们通过超声心动图评估 LVEF、整体纵向应变(GLS)和机械弥散(MD)。室性心律失常定义为持续性室性心动过速、心脏性猝死或 ICD 适当电击。
我们纳入了 290 名患者(67±13 岁,74%为男性,207(71%)为 ICM)。在 22±12 个月的随访期间,32 名(11%)患者发生了 VA。MD 和 GLS 都是 ICM 和 NICM 患者 VA 的标志物,而 LVEF 不是(p=0.14)。MD 独立预测 VA(HR:1.19;95%CI 1.08-1.32,p=0.001),MD<70ms 的患者心律失常无复发生存率良好(Log rank p<0.001)。MD<70ms 的 NICM 患者的 VA 发生率最低,年发生率为 3%,而 MD>70ms 的 ICM 患者的 VA 发生率最高,年发生率为 16%。
NICM 且 MD 正常的患者心律失常发生率较低,与一般人群相当。MD>70ms 的 ICM 患者 VA 风险最高。结合心力衰竭病因和应变超声心动图,可将心力衰竭患者分为 VA 低、中、高风险人群,从而辅助 ICD 决策策略。